Scotch Plains, NJ, United States of America

Zhen Li

USPTO Granted Patents = 5 


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Scotch Plains, NY (US) (2001)
  • Scotch Plains, NJ (US) (2001 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Zhen Li: Innovator in Pharmaceutical Chemistry

Introduction

Zhen Li is a prominent inventor based in Scotch Plains, NJ (US), known for his significant contributions to pharmaceutical chemistry. With a total of 5 patents, he has made remarkable advancements in the field, particularly in the treatment of inflammatory conditions.

Latest Patents

Among his latest patents, Zhen Li has developed p38 kinase inhibiting agents. These compounds, described by the chemical formula (I) or pharmaceutically acceptable salts thereof, serve as inhibitors of p38 and are beneficial in treating various inflammatory conditions. These include rheumatoid arthritis, osteoarthritis, and other arthritic conditions, as well as inflammatory skin conditions like eczema and psoriasis. Additionally, he has patented N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates, and tetrazoles as Edg receptor agonists. These compounds are useful for treating immune-mediated diseases, including organ and tissue transplant rejection.

Career Highlights

Zhen Li has worked with notable companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

Throughout his career, Zhen Li has collaborated with esteemed colleagues, including Jeffrey John Hale and Sander G Mills. These partnerships have further enhanced his research and development efforts.

Conclusion

Zhen Li's contributions to pharmaceutical chemistry and his innovative patents have made a significant impact in the field of medicine. His work continues to pave the way for advancements in the treatment of inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…